-- Preliminary unaudited net revenues from global sales of IMCIVREE ® (setmelanotide) of approximately $42 million for the fourth quarter of 2024 and approximately $130 million for the full year of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback